Taken together, our data clearly suggest that combined analyses of anemia and the percentage of CD163+EPOR+ TAMs were a better predictor for recurrence and survival in osteosarcoma lung metastasis patients than analyzing individual factors. The gene discussed is CD163; the disease is anemia (phenotype).